Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve.

Abstract

Pulmonary percutaneous valve implantation (PPVI) is feasible with satisfactory mid-term results in patients with native right ventricular outflow tract (RVOT) and has been increasingly used instead of surgically implantable pulmonary valves. Creating a stable landing zone with a diameter less than the largest commercially available valve (previously available 29 mm and currently available 32 mm) is crucial for technical success of the procedure, limiting the number of suitable candidates for PPVI. We report the case of PPVI with a 32 mm Myval transcatheter heart valve in a patient with a large native RVOT (pre-stented with AndraStent XXL mounted on a 35 × 60 mm valve balloon catheter) lesion who had Tetralogy of Fallot surgically corrected. The post-procedural outcomes of this case were satisfactory with no complications reported during the hospital stay.

• Authors: Alejandro Rodríguez Ogando, Fernando Ballesteros, Jose Luis Zunzunegui Martínez
• Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (Catheter Cardiovasc Interv) Vol. 99 Issue 1 Pg. E38-E42 (01 01 2022) ISSN: 1522-726X [Electronic] United States
• PMID: 34674370 (Publication Type: Case Reports, Journal Article)
• Copyright: © 2021 Wiley Periodicals LLC.

Topics

• Cardiac Catheterization
• Heart Valve Prosthesis
• Heart Valve Prosthesis Implantation (adverse effects)
• Humans
• Prosthesis Design
• Pulmonary Valve (diagnostic imaging, surgery)
• Pulmonary Valve Insufficiency (diagnostic imaging, etiology, surgery)
• Treatment Outcome
• Ventricular Outflow Obstruction (diagnostic imaging, etiology, surgery)